Potential toxicity and safety evaluation of nanomaterials for the respiratory system and lung cancer
Thomais Vlachogianni,1 Konstantinos Fiotakis,1 Spyridon Loridas,1 Stamatis Perdicaris,2 Athanasios Valavanidis1 1Department of Chemistry, Free Radicals Research Group, 2Faculty of Pharmacy, Department of Pharmacognosy and Natural Product Chemistry, University of Athens, Athens, Greece Abstract: Engi...
Saved in:
Main Authors: | Vlachogianni T, Fiotakis K, Loridas S, Perdicaris S, Valavanidis A |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/8f1b91a9a596470b9c4957ee77b70bd2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Profile of bavituximab and its potential in the treatment of non-small-cell lung cancer
by: Stasi I, et al.
Published: (2014) -
Clinical potential of nintedanib for the second-line treatment of advanced non-small-cell lung cancer: current evidence
by: Rothschild SI
Published: (2014) -
Phase III double-blind study comparing the efficacy and safety of proposed biosimilar MYL-1402O and reference bevacizumab in stage IV non-small-cell lung cancer
by: Mark A. Socinski, et al.
Published: (2021) -
Lung cancer in women
by: Barrera-Rodriguez R, et al.
Published: (2012) -
Hepatoid Adenocarcinoma of the Lung
by: Meihui Li, et al.
Published: (2021)